Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Anticancer Research
|
December 30, 2023
Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers
Kensuke Bekku, Manuela Schmidinger, Satoshi Katayama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2003
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy
Richard Crevenna, Georg Zettinig, Mohammad Keilani, et al.
Critical Reviews in Oncology/Hematology
|
November 8, 2019
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers
Eleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
European Urology
|
November 11, 2020
The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis
Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al.
Critical Reviews in Oncology/Hematology
|
April 29, 2020
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers
Eleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
BMC Cancer
|
September 8, 2010
Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma
Ursula M Vogl, Marija Bojic, Wolfgang Lamm, et al.
Journal of Neuro-Oncology
|
June 20, 2021
The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor
Anna Cho, Helena Untersteiner, Fabian Fitschek, et al.
ESMO Open
|
November 16, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
Barbara Kiesewetter, Markus Raderer, Günther G Steger, et al.
Urologic Oncology
|
April 21, 2026
Venous thromboembolism in patients with urothelial carcinoma receiving systemic therapy
Irene Huebner-Resch, Nicolai A Huebner, Regina Girgis, et al.
European Journal of Neurology
|
June 2, 2026
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study
Anna Grisold, Angelika M Starzer, Sara Silvaieh, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Anticancer Research
|
December 30, 2023
Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers
Kensuke Bekku, Manuela Schmidinger, Satoshi Katayama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2003
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy
Richard Crevenna, Georg Zettinig, Mohammad Keilani, et al.
Critical Reviews in Oncology/Hematology
|
November 8, 2019
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers
Eleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
European Urology
|
November 11, 2020
The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis
Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al.
Critical Reviews in Oncology/Hematology
|
April 29, 2020
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers
Eleonora Rofi, Marzia Del Re, Elena Arrigoni, et al.
BMC Cancer
|
September 8, 2010
Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma
Ursula M Vogl, Marija Bojic, Wolfgang Lamm, et al.
Journal of Neuro-Oncology
|
June 20, 2021
The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor
Anna Cho, Helena Untersteiner, Fabian Fitschek, et al.
ESMO Open
|
November 16, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
Barbara Kiesewetter, Markus Raderer, Günther G Steger, et al.
Urologic Oncology
|
April 21, 2026
Venous thromboembolism in patients with urothelial carcinoma receiving systemic therapy
Irene Huebner-Resch, Nicolai A Huebner, Regina Girgis, et al.
European Journal of Neurology
|
June 2, 2026
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study
Anna Grisold, Angelika M Starzer, Sara Silvaieh, et al.
Page
of 12